ポリメラーゼ連鎖反応（PCR）の世界市場レポート 2025年

ポリメラーゼ連鎖反応（PCR）の市場規模は今後数年で急成長が見込まれます。2029年には10.6%の複合年間成長率（CAGR）で189億7,000万米ドルに成長します。予測期間の成長は、食品の安全性に対する懸念の高まり、安全で高品質な食品に対する需要の増加、分子診断に対する需要の高まり、個別化医療に対する需要、デジタルポリメラーゼ連鎖反応（dPCR）への注目などに起因しています。予測期間の主な動向には、リアルタイムポリメラーゼ連鎖反応、DNAシーケンス技術、診断検査の進歩、次世代シーケンス（NGS）、マイクロ流体工学、ラボオンチッププラットフォーム、高度分子診断ソリューション開発などが含まれます。

個別化医療に対する需要の高まりは、ポリメラーゼ連鎖反応（PCR）市場の成長を促進すると予想されます。個別化医療は精密医療とも呼ばれ、ヘルスケアにおける意思決定、実践、介入、治療を患者一人ひとりの特性に合わせることを含みます。個別化医療の需要は、データ解析の進歩、患者固有の治療反応、個々の遺伝子プロファイルに基づく治療のカスタマイズ能力により増加しています。PCRは、特定の遺伝子配列の増幅と分析を可能にし、臨床医がオーダーメイドの治療計画を立てることを可能にすることで、個別化医療において重要な役割を果たしています。例えば、米国を拠点とする専門家会員組織である個別化医療連合によると、2022年には12の個別化新薬の承認が新たに承認された治療法全体の約34％を占め、以前より大幅に増加しています。このように、個別化医療に対する需要の高まりがPCR市場の成長を後押ししています。

PCR市場の主要企業はリアルタイムポリメラーゼ連鎖反応（RT-PCR）検査キットを開発し、遺伝子解析の精度、効率、使いやすさを向上させています。RT-PCRは、特定のDNA配列をリアルタイムで増幅・定量する実験室開発の検査です。例えば、2022年11月、米国の分子診断会社であるCepheid社は、FDA承認のマルチプレックスPCR検査であるXpert Xpress Multiplex Vaginal Panel（MVP）を発売しました。この検査は、リアルタイムのモニタリング、定量化、感度と特異性の向上により、従来のPCR法を強化し、分子生物学および臨床診断において重要なツールとなっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ポリメラーゼ連鎖反応（PCR） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のポリメラーゼ連鎖反応（PCR）市場：成長率分析
• 世界のポリメラーゼ連鎖反応（PCR）市場の実績：規模と成長, 2019-2024
• 世界のポリメラーゼ連鎖反応（PCR）市場の予測：規模と成長, 2024-2029, 2034F
• 世界ポリメラーゼ連鎖反応（PCR）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のポリメラーゼ連鎖反応（PCR）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来のポリメラーゼ連鎖反応
• その他のタイプ
• 世界のポリメラーゼ連鎖反応（PCR）市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 腫瘍学
• 遺伝性疾患
• その他の適応症
• 世界のポリメラーゼ連鎖反応（PCR）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医学
• 非医療
• 世界のポリメラーゼ連鎖反応（PCR）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 製薬およびバイオテクノロジー産業
• 診断センター
• 学術調査機関
• 世界のポリメラーゼ連鎖反応（PCR）市場、従来のポリメラーゼ連鎖反応の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エンドポイントPCR
• ゲル電気泳動法によるPCR
• 逆転写PCR（Rt-PCR）
• 遺伝子発現のための定量PCR（Qpcr）
• ネストされたPCR
• 世界のポリメラーゼ連鎖反応（PCR）市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リアルタイムPCR（Qpcr）（定量PCR）
• デジタルPCR（Dpcr）
• マルチプレックスPCR
• 逆転写定量PCR（Rt-Qpcr）
• 等温増幅（ランプ）
• 次世代PCR（NGSベースのPCR技術）
• ハイスループットPCR

第7章 地域別・国別分析

• 世界のポリメラーゼ連鎖反応（PCR）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のポリメラーゼ連鎖反応（PCR）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポリメラーゼ連鎖反応（PCR）市場：競合情勢
• ポリメラーゼ連鎖反応（PCR）市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson and Company
• GE HealthCare Technologies Inc
• Laboratory Corporation of America Holdings（LabCorp）
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• bioMerieux SA
• Beckman Coulter Inc
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Natera Inc.
• Myriad Genetics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ポリメラーゼ連鎖反応（PCR）市場2029：新たな機会を提供する国
• ポリメラーゼ連鎖反応（PCR）市場2029：新たな機会を提供するセグメント
• ポリメラーゼ連鎖反応（PCR）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Polymerase chain reaction (PCR) is a laboratory technique employed to amplify specific segments of DNA. This process involves repeated cycles of heating and cooling to denature, anneal, and extend DNA strands, leading to the exponential amplification of the target sequence.

The main types of PCR are conventional polymerase chain reaction and other variants. Conventional PCR is used to amplify a specific DNA segment through repeated heating and cooling cycles. It is utilized in diagnosing various conditions such as infectious diseases, oncology, and genetic disorders. Its applications span both medical and non-medical fields, including hospitals and clinics, pharmaceutical and biotechnology industries, diagnostic centers, and academic and research organizations.

The polymerase chain reaction (PCR) market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction (PCR) market statistics, including polymerase chain reaction (PCR) industry global market size, regional shares, competitors with a polymerase chain reaction (PCR) market share, detailed polymerase chain reaction (PCR) market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction (PCR) industry. This polymerase chain reaction (PCR) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polymerase chain reaction (PCR) market size has grown rapidly in recent years. It will grow from $11.42 billion in 2024 to $12.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising number of research facilities, increasing number of patients for chronic and infectious diseases, increasing prevalence of genetic and chronic disorders, increasing population, and growing geriatric population.

The polymerase chain reaction (PCR) market size is expected to see rapid growth in the next few years. It will grow to $18.97 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to the rising concerns over food safety, the increasing demand for safe and high-quality food products, the rising demand for molecular diagnostics, demand for personalized medicine, focus on digital polymerase chain reaction (dPCR). Major trends in the forecast period include real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

The rising demand for personalized medicine is anticipated to drive the growth of the polymerase chain reaction (PCR) market. Personalized medicine, also known as precision medicine, involves tailoring healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to customize therapies based on individual genetic profiles. PCR plays a crucial role in personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to create tailored treatment plans. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, indicating a significant increase from previous years. Thus, the growing demand for personalized medicine is fueling the growth of the PCR market.

Leading companies in the PCR market are developing real-time polymerase chain reaction (RT-PCR) test kits to improve the accuracy, efficiency, and ease of use in genetic analysis. RT-PCR is a laboratory-developed test that amplifies and quantifies specific DNA sequences in real time. For example, in November 2022, Cepheid, a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test that detects DNA from organisms associated with three distinct vaginal infections-bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis-from a single vaginal swab sample. This test enhances traditional PCR methods by providing real-time monitoring, quantification, and increased sensitivity and specificity, making it a crucial tool in molecular biology and clinical diagnostics.

In April 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology company, partnered with R-Biopharm AG for an undisclosed amount. The partnership aims to develop innovative PCR tests for multiresistant bacteria and strengthen their presence in the global clinical diagnostics market. R-Biopharm AG is a Germany-based biotechnology company specializing in clinical diagnostics.

Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polymerase chain reaction (PCR) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction (PCR) market consists of revenues earned by entities by providing services such as DNA amplification, gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, gene cloning, genotyping and mutation detection, pathogen detection, technical support, training, and troubleshooting assistance to researchers and laboratory professionals using their products. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction (PCR) market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, nucleotides, centrifuges, primers, pipettes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction (PCR) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction (pcr) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction (pcr) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction (pcr) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Conventional Polymerase Chain Reaction; Other Types
• 2) By Indication: Infectious Diseases; Oncology; Genetic Disorders; Other Indications
• 3) By Application: Medical; Non-Medical
• 4) By End User: Hospitals And Clinics; Pharmaceutical And Biotechnology Industries; Diagnostic Centers; Academic And Research Organization
• Subsegments:
• 1) By Conventional Polymerase Chain Reaction: Endpoint Pcr; Gel Electrophoresis-Based Pcr; Reverse Transcription Pcr (Rt-Pcr); Quantitative Pcr (Qpcr) For Gene Expression; Nested Pcr
• 2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr); Digital Pcr (Dpcr); Multiplex Pcr; Reverse Transcription-Quantitative Pcr (Rt-Qpcr); Isothermal Amplification (Lamp); Next-Generation Pcr (Ngs-Based Pcr Techniques); High-Throughput Pcr
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction (PCR) Market Characteristics

3. Polymerase Chain Reaction (PCR) Market Trends And Strategies

4. Polymerase Chain Reaction (PCR) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Polymerase Chain Reaction (PCR) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Polymerase Chain Reaction (PCR) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Polymerase Chain Reaction (PCR) Market Growth Rate Analysis
• 5.4. Global Polymerase Chain Reaction (PCR) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Polymerase Chain Reaction (PCR) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Polymerase Chain Reaction (PCR) Total Addressable Market (TAM)

6. Polymerase Chain Reaction (PCR) Market Segmentation

• 6.1. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Polymerase Chain Reaction
• Other Types
• 6.2. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Oncology
• Genetic Disorders
• Other Indications
• 6.3. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Non-Medical
• 6.4. Global Polymerase Chain Reaction (PCR) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Industries
• Diagnostic Centers
• Academic And Research Organization
• 6.5. Global Polymerase Chain Reaction (PCR) Market, Sub-Segmentation Of Conventional Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endpoint Pcr
• Gel Electrophoresis-Based Pcr
• Reverse Transcription Pcr (Rt-Pcr)
• Quantitative Pcr (Qpcr) For Gene Expression
• Nested Pcr
• 6.6. Global Polymerase Chain Reaction (PCR) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Pcr (Qpcr) (Quantitative Pcr)
• Digital Pcr (Dpcr)
• Multiplex Pcr
• Reverse Transcription-Quantitative Pcr (Rt-Qpcr)
• Isothermal Amplification (Lamp)
• Next-Generation Pcr (Ngs-Based Pcr Techniques)
• High-Throughput Pcr

7. Polymerase Chain Reaction (PCR) Market Regional And Country Analysis

• 7.1. Global Polymerase Chain Reaction (PCR) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Polymerase Chain Reaction (PCR) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction (PCR) Market

• 8.1. Asia-Pacific Polymerase Chain Reaction (PCR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction (PCR) Market

• 9.1. China Polymerase Chain Reaction (PCR) Market Overview
• 9.2. China Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction (PCR) Market

• 10.1. India Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction (PCR) Market

• 11.1. Japan Polymerase Chain Reaction (PCR) Market Overview
• 11.2. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction (PCR) Market

• 12.1. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction (PCR) Market

• 13.1. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction (PCR) Market

• 14.1. South Korea Polymerase Chain Reaction (PCR) Market Overview
• 14.2. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction (PCR) Market

• 15.1. Western Europe Polymerase Chain Reaction (PCR) Market Overview
• 15.2. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction (PCR) Market

• 16.1. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction (PCR) Market

• 17.1. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction (PCR) Market

• 18.1. France Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction (PCR) Market

• 19.1. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction (PCR) Market

• 20.1. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction (PCR) Market

• 21.1. Eastern Europe Polymerase Chain Reaction (PCR) Market Overview
• 21.2. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction (PCR) Market

• 22.1. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction (PCR) Market

• 23.1. North America Polymerase Chain Reaction (PCR) Market Overview
• 23.2. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction (PCR) Market

• 24.1. USA Polymerase Chain Reaction (PCR) Market Overview
• 24.2. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction (PCR) Market

• 25.1. Canada Polymerase Chain Reaction (PCR) Market Overview
• 25.2. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction (PCR) Market

• 26.1. South America Polymerase Chain Reaction (PCR) Market Overview
• 26.2. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction (PCR) Market

• 27.1. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction (PCR) Market

• 28.1. Middle East Polymerase Chain Reaction (PCR) Market Overview
• 28.2. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction (PCR) Market

• 29.1. Africa Polymerase Chain Reaction (PCR) Market Overview
• 29.2. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction (PCR) Market Competitive Landscape And Company Profiles

• 30.1. Polymerase Chain Reaction (PCR) Market Competitive Landscape
• 30.2. Polymerase Chain Reaction (PCR) Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction (PCR) Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson and Company
• 31.2. GE HealthCare Technologies Inc
• 31.3. Laboratory Corporation of America Holdings (LabCorp)
• 31.4. Quest Diagnostics Incorporated
• 31.5. Eurofins Scientific
• 31.6. Agilent Technologies Inc.
• 31.7. Illumina Inc.
• 31.8. PerkinElmer Inc.
• 31.9. bioMerieux SA
• 31.10. Beckman Coulter Inc
• 31.11. Sysmex Corporation
• 31.12. Bio-Rad Laboratories Inc.
• 31.13. Qiagen N.V.
• 31.14. Natera Inc.
• 31.15. Myriad Genetics Inc.

32. Global Polymerase Chain Reaction (PCR) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Market

34. Recent Developments In The Polymerase Chain Reaction (PCR) Market

35. Polymerase Chain Reaction (PCR) Market High Potential Countries, Segments and Strategies

• 35.1 Polymerase Chain Reaction (PCR) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Polymerase Chain Reaction (PCR) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Polymerase Chain Reaction (PCR) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer